SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 3, 2010
Orchid Cellmark Inc.
(Exact name of the registrant as specified in its charter)
4390 US Route One, Princeton, NJ 08540
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (609) 750-2200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
On September 7, 2010, Orchid Cellmark Inc. (the Company) and Accipiter Capital Management, LLC (Accipiter) jointly announced that the Company and Accipiter (together with its affiliates) had reached an agreement in connection with the nomination of candidates for election to the Companys Board of Directors.
A copy of the settlement agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K.
A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.